𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate

✍ Scribed by A.E. Steen; K.H. Steen; R. Bauer; T. Bieber

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
384 KB
Volume
145
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Etoposide in the treatment of six childr
Etoposide in the treatment of six children with langerhans cell histiocytosis (histiocytosis X)
✍ Viana, Marcos Borato ;Oliveira, Benigna Maria ;Silva, Celia Maria ;Leite, Virgin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 548 KB

Six children received etoposide as the single agent for treatment of Langerhans cell histiocytosis (LCH; histiocytosis X). Five were less than 2 years old at diagnosis. All had multiorgan involvement; one had liver and pulmonary dysfunction. Two infants also had clinical signs of immune deficiency.

β€œEtoposide in the treatment of six child
β€œEtoposide in the treatment of six children with langerhans cell histiocytosis (histiocytosis X)” by Viana et al.
✍ Whitlock, James A. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

Viana et al. [I] described their experience with etoposide (VP-16) as initial therapy in the management of patients with Langerhans cell histiocytosis (LCH). However, caution should be used in advocating the use of an epipodophyllotoxin as the "drug of choice" for the treatment of this disorder. Alt